Biocept Inc (OTCPK:BIOCQ)
$ 0.0002 0 (0%) Market Cap: 1,000.00 Enterprise Value: 4.96 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Biocept Inc Announces Highmark Makes A Positive Coverage Determination on Target Selector Liquid Biopsy Transcript

Sep 23, 2020 / NTS GMT
Release Date Price: $126.9 (-8.04%)
Steve Darling
Proactive Investors - Moderator

All right, welcome back inside our Proactive Newsroom. [Joining me right now] is Michael Nall, the CEO of Biocept. And Mike, good to see it. How are you?

Michael Nall
Biocept, Inc. - President & CEO

Doing good. Great to see you as well.

Questions & Answers

Steve Darling
Proactive Investors - Moderator

So interesting news release out today. Dealing with a company called a Highmark, and I think before we go any further, maybe you can explain to everyone what Highmark is and what they do?

Michael Nall
Biocept, Inc. - President & CEO

Sure. Well, Highmark is one of the largest Blue Cross plans in America. And so they're kind of unique in that they also own their own health care delivery system called Allegheny Regional. And in Western Pennsylvania, it's one of the largest health care delivery systems out there. And they have a program that they work with industry called VITALS program.

And what they do

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot